IRIS
PASSINO, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.059
EU - Europa 18.752
AS - Asia 4.372
SA - Sud America 160
Continente sconosciuto - Info sul continente non disponibili 107
OC - Oceania 54
AF - Africa 44
Totale 49.548
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.629
GB - Regno Unito 6.471
IT - Italia 3.506
UA - Ucraina 2.202
SG - Singapore 1.748
DE - Germania 1.699
DK - Danimarca 1.521
CA - Canada 1.340
CN - Cina 1.087
VN - Vietnam 873
RU - Federazione Russa 833
SE - Svezia 667
IE - Irlanda 518
FI - Finlandia 406
FR - Francia 346
PL - Polonia 277
HK - Hong Kong 263
EU - Europa 106
NL - Olanda 91
BR - Brasile 78
MX - Messico 76
IN - India 69
PK - Pakistan 67
IR - Iran 56
KR - Corea 53
AU - Australia 43
RO - Romania 34
JP - Giappone 27
BE - Belgio 26
SK - Slovacchia (Repubblica Slovacca) 25
ES - Italia 24
AT - Austria 23
CH - Svizzera 20
BD - Bangladesh 19
AR - Argentina 16
EC - Ecuador 16
PE - Perù 16
CO - Colombia 15
TR - Turchia 15
ID - Indonesia 14
ET - Etiopia 12
TW - Taiwan 12
AM - Armenia 11
CZ - Repubblica Ceca 11
LT - Lituania 11
NZ - Nuova Zelanda 11
SA - Arabia Saudita 11
BO - Bolivia 8
PT - Portogallo 8
CL - Cile 6
GH - Ghana 6
PH - Filippine 6
KE - Kenya 5
KG - Kirghizistan 5
ZA - Sudafrica 5
EE - Estonia 4
IL - Israele 4
KZ - Kazakistan 4
MA - Marocco 4
MY - Malesia 4
TN - Tunisia 4
VE - Venezuela 4
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
LU - Lussemburgo 3
LV - Lettonia 3
SC - Seychelles 3
SM - San Marino 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BY - Bielorussia 2
CR - Costa Rica 2
EG - Egitto 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MG - Madagascar 2
MK - Macedonia 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
IQ - Iraq 1
IS - Islanda 1
JO - Giordania 1
KW - Kuwait 1
MM - Myanmar 1
NG - Nigeria 1
PS - Palestinian Territory 1
PY - Paraguay 1
Totale 49.547
Salva come PNG Salva come JPEG
Città #
Southend 4.837
Woodbridge 2.672
Chandler 2.319
Ann Arbor 2.295
Houston 2.019
Fairfield 1.626
San Mateo 1.470
Singapore 1.377
Falls Church 1.263
Jacksonville 1.089
Dearborn 1.020
Seattle 1.012
Cambridge 956
Ottawa 853
Wilmington 841
Ashburn 718
Beijing 606
Pisa 542
Stevenage 512
Boardman 504
Dublin 495
Portsmouth 488
Dong Ket 483
Montréal 403
Lawrence 385
Warsaw 267
Redwood City 174
Santa Clara 172
Rome 171
San Diego 168
Milan 159
Old Bridge 158
Brooklyn 150
London 140
Fremont 110
Florence 95
Helsinki 92
Munich 82
Hong Kong 67
Norwalk 67
Central District 60
Los Angeles 55
Livorno 52
Washington 47
Buti 42
Frankfurt am Main 41
Shenzhen 36
Seoul 35
Lappeenranta 33
Serra 33
Nanjing 31
Wayne 31
Lucca 30
Bologna 28
Chiswick 28
Foggia 28
Salisbury 28
Shanghai 27
Toronto 27
Assago 26
Genoa 26
Kansas City 26
Padova 26
Bratislava 25
Naples 25
Augusta 23
Hounslow 23
Turin 23
Wandsworth 23
Hanover 20
Sydney 20
Dallas 19
Jinan 19
Provo 19
Brussels 18
Guangzhou 18
Hefei 18
Islamabad 18
Nuremberg 18
Palermo 18
Bari 17
Cardiff 17
Dongguan 17
Fuzhou 17
Pavia 17
Simi Valley 17
Amsterdam 16
Cascina 16
Kish 16
Napoli 16
Redmond 16
Bucharest 14
Glasgow 14
Mexico 14
Perugia 14
West Jordan 14
Berlin 13
Chicago 13
Kilburn 13
Krefeld 13
Totale 34.304
Salva come PNG Salva come JPEG
Nome #
Value in Healthcare and the Role of the Patient Voice 700
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 577
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 252
La neuropatia diabetica 244
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 240
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 220
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 215
Grapevine microRNAs in an in vitro model of cell line: new potential insight on their role in the setting of human health. 212
Functional ancient grain bread rich in iron, zinc, flavonoids and alpha lipoic acid attenuates post-ischemic myocardial remodeling in rats 207
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 199
Influence of Type of Surgery on the Occurrence of Parasympathetic Reinnervation After Cardiac Transplantation 191
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 187
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 184
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 181
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 180
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 179
Human pathophysiological adaptations to the space environment 177
Usefulness of high-sensitive troponin elevation after effort stress to unveil vulnerable myocardium in patients with hart failure 177
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 176
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: A cardiac MR study 175
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 174
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 174
Tuscany Sangiovese Grape juice imparts cardioprotection by regulating gene expression of Cardioprotective C-Type Natriuretic Peptide. 172
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 171
Treating chemoreflex in heart failure: modulation or demolition? 168
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 167
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 164
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 164
Radioimmunoassay for plasma C-type natriuretic peptide determination: a methodological evaluation 163
B-type natriuretic peptide secretion following scuba diving 163
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 163
Marcatori di rimodellamento e fibrosi cardiaca 163
Prognostic Value of Indeterminable Anaerobic Threshold in Heart Failure. 162
Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance 160
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption 159
Attivazione adrenergica e deattivazione parasimpatica nello scompenso cardiaco. 158
Haematological modifications after acute exposure to high altitude: possible implications for detection of recombinant erythropoietin misuse. 158
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. 158
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 157
Prognostic value of combined use of B-ype natriuretic peptides and interleukine-6 in predicting cardiac mortalità in end-stage renal disease patients 157
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 157
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 157
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 157
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay of the N-terminal fragment of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. 156
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. 155
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 155
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 155
These abstracts have been selected for moderated presentations on SCREEN A. Please refer to the the PROGRAM and the infos on the screen for more details about schedule, moderators and presenters. 154
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 153
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 153
Bioinformatics analysis of the gene profile of coronary endothelial cells treated with Grapevine microRNAs: an in vitro study 153
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 153
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 153
Cardiac production of C-type natriuretic peptide in heart failure. 152
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 152
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 151
Update sui biomarcatori nello scompenso cardiaco. 151
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 151
Prognostic value of alveolar volume in systolic heart failure: a prospective observational study 150
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 150
Cheyne-Stokes Respiration, Chemoreflex, and Ticagrelor-Related Dyspnea 150
Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method 150
C-type natriuretic peptide and heart failure 149
Hyperthyroidism is associated with lengthening of ventricular repolarization. 149
Can we measure how hot the plaque is? Not yet, but…. 149
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice 148
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 148
Comparison of the diagnostic accuracy of BNP and NT-proBNP in acute and chronic heart failure. Reply Letter 147
Influence of ScaI and Natriuretic Peptide (NP) Clearance Receptor Polymorphisms of the NP System on NP Concentration in Chronic Heart Failure. 147
Different substrates of non-sustained ventricular tachycardia in post-infarction patients with and without left ventricular dilatation. 147
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 147
Demonstrable Cardiac Reinnervation After Human Heart Transplantation by Carotid Baroreflex Modulation of RR Interval 146
Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure. 146
Exercise intolerance in chronic heart failure: mechanisms and therapies. Part I. 146
The combined use of neutrophil gelatinase-associated lipocalin and brain natriuretic peptide improves risk stratification in pediatric cardiac surgery 146
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 146
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 145
Cerebral vasoreactivity in Andeans and headache at sea level. 145
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 145
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 145
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 145
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 144
Refractory hyperaldosteronism in heart failure is associated with plasma renin activity and angiotensinogen polymorphism 144
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: Data from the MECKI Score Research Group 144
New and emerging biomarkers of heart failure 143
Changes in chemoreflex characteristics following acetazolamide administration in patients with chronic heart failure and Cheyne Stokes respiration 143
Neuro-hormonal activation predicts ventilatory response to exercise and functional capacity in patients with heart failure. 141
Natriuretic peptide testing in primary care patients. 140
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 140
When chronic heart failure intersects chronic obstructive pulmonary disease: impact on long-term prognosis 140
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 140
The metabolic exercise test data combined with Cardiac and Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 140
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 140
Prognostic complexity of heart failure and network analysis: the holistic risk stratification 139
Comparison of the Diagnostic Accuracy of Brain Natriuretic Peptide (BNP) and the N-Terminal Part of the Propeptide of BNP Immunoassays in Chronic and Acute Heart Failure: A Systematic Review 139
N-terminal fragment of brain natriuretic peptide predicts vascular health and subclinical atherosclerosis: results from MEHLP study 139
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 139
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 138
Plasma gamma-glutamyltransferase fractions: diagnostic and prognostic predictive value 138
Clinical relevance of time course of BNP levels in neonates with congenital heart diseases 138
Totale 16.971
Salva come PNG Salva come JPEG
Categoria #
all - tutte 299.041
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 299.041
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.564 0 0 0 0 0 0 833 233 609 122 152 615
2020/202110.274 719 1.145 522 924 636 1.457 917 604 630 623 744 1.353
2021/20226.927 477 1.282 379 663 153 119 764 1.269 561 670 114 476
2022/20235.337 402 312 276 790 779 826 53 432 917 106 244 200
2023/20243.247 292 112 528 227 210 337 303 190 191 167 168 522
2024/20254.442 192 234 1.198 489 999 1.286 44 0 0 0 0 0
Totale 50.159